No abstract available
Keywords:
DLX105; PASI; TNF-α; specific therapy; topical administration.
Publication types
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Administration, Topical
-
Humans
-
Psoriasis*
-
Severity of Illness Index
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha*
Substances
-
Tumor Necrosis Factor-alpha